AusGo-SHEMO….Let’s Go! Australian Gold Standard Health Economics Model Of Osteoporosis
Funder
National Health and Medical Research Council
Funding Amount
$378,959.00
Summary
We will develop an unbiased, gold standard, validated, transparent health economics model of osteoporosis to identify cost-effective screening and treatment strategies, and that will be made widely available to all stakeholders. Without this model, scarce health care resources may be squandered on osteoporosis screening strategies and osteoporosis-related fracture prevention medications that are not cost-effective. Worse, patient access to cost-effective medications may be delayed.
Evaluation Of Alcohol Management Plans (AMPs), Cape York, North Queensland
Funder
National Health and Medical Research Council
Funding Amount
$626,395.00
Summary
The study will describe long-term impacts on important health and social outcomes of restricting alcohol in Cape York, Queensland. It will assess the impacts and cost-effectiveness of the Queensland Government’s Alcohol Management Plans implemented from 2002-03. The researchers will use de-identified data on injury, violence, health and social indicators. The study will map whether AMP components were delivered as promised and the extent to which they were welcomed by Cape York communities.
Cost-effective Development And Validation Of Risk Prediction Models: Methods And Applications
Funder
National Health and Medical Research Council
Funding Amount
$157,322.00
Summary
We will develop statistical methods and software that will enable risk calculators being built and validated using study designs that require only a fraction of current cost. The methods and software will be freely-available to researchers worldwide.
Modelling The Cost-effectiveness Of Therapeutic Strategies For Invasive Candidiasis Among The ICU Population
Funder
National Health and Medical Research Council
Funding Amount
$282,733.00
Summary
ICU patients are vulnerable to fungal infections during their stay in hospital. These infections are costly to treat and pose real dangers to the patient with up to 1270 lives lost each year. The best way to diagnose and treat these infections is currently not known. Making an early and accurate diagnosis is difficult but important if the infection is to be managed appropriately. This research will show which management strategies are optimal for patients and health services.
Optimising Upper Limb Recovery Following Stroke: A Randomised Controlled Trial Of The Effects Of Botulinum Toxin-A Combined With Intensive Rehabilitation Compared To Botulinum Toxin-A Alone
Funder
National Health and Medical Research Council
Funding Amount
$1,070,230.00
Summary
The devastating loss of movement in the hand after stroke could potentially be addressed, but we currently lack of research investigating treatment interventions. This randomised controlled trial will compare the routine interventions of botulinum toxin to botulinum toxin plus best-practice therapy for both cost and clinical outcome. Findings from this trial will provide the necessary information to make decisions about what will improve spasticity and function in the hand and arm after stroke.
AVERT-DOSE (Determining Optimal Early Rehabilitation After StrokE): A Multi-arm Covariate-adjusted, Response-adaptive Randomised Controlled Trial
Funder
National Health and Medical Research Council
Funding Amount
$4,359,564.00
Summary
AVERT-DOSE is an international, investigator-led clinical trial, developed in Australia but recruiting >2500 patients from 6 countries around the world. In this trial we will establish the optimal model of early mobility rehabilitation for people with acute stroke. The protocols we develop will be suitable for adoption in clinical practice in developed and developing countries and help reduce the unacceptably high personal and community burden of stroke-related disability world wide.
Effectiveness, Cost-effectiveness And Cost-benefit Of A Single Annual Professional Intervention For The Prevention Of Childhood Dental Caries In A Remote Rural Indigenous Community
Funder
National Health and Medical Research Council
Funding Amount
$1,050,869.00
Summary
The aim of the study is to reduce the high prevalence of tooth decay in children in a remote, rural Indigenous community, by application of a single annual dental preventive intervention. Most dental preventive interventions require regular re-application (3 monthly), which is not possible in resource constrained communities. Importantly, the study will assess cost-benefit and cost-effectiveness for broader implementation across similar communities in Australia and internationally.
Costing The Place Of Birth In NSW: New Knowledge To Support Maternity Service Reform
Funder
National Health and Medical Research Council
Funding Amount
$269,478.00
Summary
The comparative costs of giving birth at home, in a birth centre or in a hospital labour ward is unknown. This study will build on the current Birthplace in Australia Study to provide much needed evidence to inform policy and health service allocation decisions in Australian maternity care.
Pregabalin In Addition To Usual Care For Sciatica (PRECISE): A Randomised, Placebo-controlled Trial
Funder
National Health and Medical Research Council
Funding Amount
$638,663.00
Summary
Sciatica is a severe and disabling form of back pain that is characterised by radiating pain down the leg. However there is little evidence on how best to treat it conservatively. We propose to investigate the effectiveness of pregabalin, a medication that specifically targets sciatic pain, in addition to usual care in 204 patients with sciatica. We hypothesise that adding pregabalin will be more effective in reducing the severity of leg pain.
Improving Outcomes For People With Depression In Community Settings: A Cluster RCT
Funder
National Health and Medical Research Council
Funding Amount
$803,554.00
Summary
Depression affects 350 million people worldwide. Given the pivotal role of primary care in the management of depression, effective strategies are needed to assist GPs in the delivery of patient-centred depression care. This study will test the effectiveness of providing GPs with education; as well as feedback about patients’ self-reported depressive scores using a standardised instrument and perceived need and preferences for help. This cluster RCT will be the first Australian trial of its kind.